Table 3. Tumour response.
Site |
|||
---|---|---|---|
Response | Nasopharynx | Neck | Overall |
Clinical | |||
CR | 66 (73.3%) | 64 (71.1%) | 52 (57.8%) |
PR | 23 (25.6%) | 24 (26.7%) | 36 (40.0%) |
SD | 1 (1.1%) | 2 (2.2%) | 2 (2.2%) |
Pathologicala | |||
CR | 55 (62.5%) | ||
Residual tumour | 33 (37.5%) |
A total of 88 out of 90 patients received rebiopsy of nasopharynx after neoadjuvant chemotherapy before radiotherapy.
CR=complete response, PR=partial response, SD=stable disease.